Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 85

1.

Posterior Cingulate Lactate as a Metabolic Biomarker in Amnestic Mild Cognitive Impairment.

Weaver KE, Richards TL, Logsdon RG, McGough EL, Minoshima S, Aylward EH, Kleinhans NM, Grabowski TJ, McCurry SM, Teri L.

Biomed Res Int. 2015;2015:610605. doi: 10.1155/2015/610605.

2.

Prediction of manifest Huntington's disease with clinical and imaging measures: a prospective observational study.

Paulsen JS, Long JD, Ross CA, Harrington DL, Erwin CJ, Williams JK, Westervelt HJ, Johnson HJ, Aylward EH, Zhang Y, Bockholt HJ, Barker RA; PREDICT-HD Investigators and Coordinators of the Huntington Study Group..

Lancet Neurol. 2014 Dec;13(12):1193-201. doi: 10.1016/S1474-4422(14)70238-8.

3.

Magnetic resonance imaging striatal volumes: a biomarker for clinical trials in Huntington's disease.

Aylward EH.

Mov Disord. 2014 Sep 15;29(11):1429-33. doi: 10.1002/mds.26013. Review.

4.

Clinical and Biomarker Changes in Premanifest Huntington Disease Show Trial Feasibility: A Decade of the PREDICT-HD Study.

Paulsen JS, Long JD, Johnson HJ, Aylward EH, Ross CA, Williams JK, Nance MA, Erwin CJ, Westervelt HJ, Harrington DL, Bockholt HJ, Zhang Y, McCusker EA, Chiu EM, Panegyres PK; PREDICT-HD Investigators and Coordinators of the Huntington Study Group..

Front Aging Neurosci. 2014 Apr 22;6:78. doi: 10.3389/fnagi.2014.00078.

5.

Neuroanatomical correlates of cognitive functioning in prodromal Huntington disease.

Harrington DL, Liu D, Smith MM, Mills JA, Long JD, Aylward EH, Paulsen JS.

Brain Behav. 2014 Jan;4(1):29-40. doi: 10.1002/brb3.185.

6.

Huntington disease: natural history, biomarkers and prospects for therapeutics.

Ross CA, Aylward EH, Wild EJ, Langbehn DR, Long JD, Warner JH, Scahill RI, Leavitt BR, Stout JC, Paulsen JS, Reilmann R, Unschuld PG, Wexler A, Margolis RL, Tabrizi SJ.

Nat Rev Neurol. 2014 Apr;10(4):204-16. doi: 10.1038/nrneurol.2014.24. Review.

PMID:
24614516
7.

Neurochemical correlates of caudate atrophy in Huntington's disease.

Padowski JM, Weaver KE, Richards TL, Laurino MY, Samii A, Aylward EH, Conley KE.

Mov Disord. 2014 Mar;29(3):327-35. doi: 10.1002/mds.25801.

8.

The association between higher order abilities, processing speed, and age are variably mediated by white matter integrity during typical aging.

Borghesani PR, Madhyastha TM, Aylward EH, Reiter MA, Swarny BR, Schaie KW, Willis SL.

Neuropsychologia. 2013 Jul;51(8):1435-44. doi: 10.1016/j.neuropsychologia.2013.03.005.

9.

Regional atrophy associated with cognitive and motor function in prodromal Huntington disease.

Aylward EH, Harrington DL, Mills JA, Nopoulos PC, Ross CA, Long JD, Liu D, Westervelt HK, Paulsen JS; PREDICT-HD Investigators and Coordinators of the Huntington Study Group..

J Huntingtons Dis. 2013;2(4):477-89. doi: 10.3233/JHD-130076.

10.

Brain volume and shape in infants with deformational plagiocephaly.

Collett BR, Aylward EH, Berg J, Davidoff C, Norden J, Cunningham ML, Speltz ML.

Childs Nerv Syst. 2012 Jul;28(7):1083-90. doi: 10.1007/s00381-012-1731-y.

11.

Striatal volume contributes to the prediction of onset of Huntington disease in incident cases.

Aylward EH, Liu D, Nopoulos PC, Ross CA, Pierson RK, Mills JA, Long JD, Paulsen JS; PREDICT-HD Investigators and Coordinators of the Huntington Study Group..

Biol Psychiatry. 2012 May 1;71(9):822-8. doi: 10.1016/j.biopsych.2011.07.030.

12.

Estimating premorbid IQ in the prodromal phase of a neurodegenerative disease.

Carlozzi NE, Stout JC, Mills JA, Duff K, Beglinger LJ, Aylward EH, Whitlock KB, Solomon AC, Queller S, Langbehn DR, Johnson SA, Paulsen JS; Predict-Hd Investigators Of The Huntington Study Group..

Clin Neuropsychol. 2011 Jul;25(5):757-77. doi: 10.1080/13854046.2011.577811.

13.

Midlife memory improvement predicts preservation of hippocampal volume in old age.

Borghesani PR, Weaver KE, Aylward EH, Richards AL, Madhyastha TM, Kahn AR, Liang O, Ellenbogen RL, Beg MF, Schaie KW, Willis SL.

Neurobiol Aging. 2012 Jul;33(7):1148-55. doi: 10.1016/j.neurobiolaging.2010.09.026.

14.

Smaller intracranial volume in prodromal Huntington's disease: evidence for abnormal neurodevelopment.

Nopoulos PC, Aylward EH, Ross CA, Mills JA, Langbehn DR, Johnson HJ, Magnotta VA, Pierson RK, Beglinger LJ, Nance MA, Barker RA, Paulsen JS; PREDICT-HD Investigators and Coordinators of the Huntington Study Group..

Brain. 2011 Jan;134(Pt 1):137-42. doi: 10.1093/brain/awq280.

15.

Neurocognitive signs in prodromal Huntington disease.

Stout JC, Paulsen JS, Queller S, Solomon AC, Whitlock KB, Campbell JC, Carlozzi N, Duff K, Beglinger LJ, Langbehn DR, Johnson SA, Biglan KM, Aylward EH.

Neuropsychology. 2011 Jan;25(1):1-14. doi: 10.1037/a0020937.

16.

Longitudinal change in regional brain volumes in prodromal Huntington disease.

Aylward EH, Nopoulos PC, Ross CA, Langbehn DR, Pierson RK, Mills JA, Johnson HJ, Magnotta VA, Juhl AR, Paulsen JS; PREDICT-HD Investigators and Coordinators of Huntington Study Group..

J Neurol Neurosurg Psychiatry. 2011 Apr;82(4):405-10. doi: 10.1136/jnnp.2010.208264.

17.

Cerebral cortex structure in prodromal Huntington disease.

Nopoulos PC, Aylward EH, Ross CA, Johnson HJ, Magnotta VA, Juhl AR, Pierson RK, Mills J, Langbehn DR, Paulsen JS; PREDICT-HD Investigators Coordinators of Huntington Study Group (HSG)..

Neurobiol Dis. 2010 Dec;40(3):544-54. doi: 10.1016/j.nbd.2010.07.014.

18.

In utero smoke exposure and impaired response to inhaled corticosteroids in children with asthma.

Cohen RT, Raby BA, Van Steen K, Fuhlbrigge AL, Celedón JC, Rosner BA, Strunk RC, Zeiger RS, Weiss ST; Childhood Asthma Management Program Research Group..

J Allergy Clin Immunol. 2010 Sep;126(3):491-7. doi: 10.1016/j.jaci.2010.06.016.

19.

Serum vitamin D levels and severe asthma exacerbations in the Childhood Asthma Management Program study.

Brehm JM, Schuemann B, Fuhlbrigge AL, Hollis BW, Strunk RC, Zeiger RS, Weiss ST, Litonjua AA; Childhood Asthma Management Program Research Group..

J Allergy Clin Immunol. 2010 Jul;126(1):52-8.e5. doi: 10.1016/j.jaci.2010.03.043.

20.

Magnetic resonance imaging outcomes from a comprehensive magnetic resonance study of children with fetal alcohol spectrum disorders.

Astley SJ, Aylward EH, Olson HC, Kerns K, Brooks A, Coggins TE, Davies J, Dorn S, Gendler B, Jirikowic T, Kraegel P, Maravilla K, Richards T.

Alcohol Clin Exp Res. 2009 Oct;33(10):1671-89. doi: 10.1111/j.1530-0277.2009.01004.x.

Items per page

Supplemental Content

Loading ...
Support Center